Tech Company Financing Transactions
Hepregen Funding Round
On 8/29/2008, Hepregen secured $3 million in Series A financing from Battelle Ventures and Innovation Valley Partners.
Transaction Overview
Company Name
Announced On
8/29/2008
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Boston Ave. 1500
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Website
Email Address
Overview
Hepregen's HepatoPac and HepatoMune liver models are the most predictive in vitro tools on the market for assessing drug metabolism and potential hepatotoxicities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vincent Zurawski
VP - Administration
Martin Joyce
VP - Operations
John McGeehan
Browse more venture capital transactions:
Prev: 8/29/2008: Percutaneous Systems venture capital transaction
Next: 8/29/2008: Peplin venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs